SCHEMBL24154469

SCHEMBL24154469

CC(C)c1ccc(-c2ccc(Sc3[nH]nnc3C(=O)O)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
EGLN1 Q9GZT9 2/20 0.36
TP53 P04637 2/20 0.36
VEGFA P15692 1/20 0.36
FLT1 P17948 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AGBL2 Q5U5Z8 1/20 0.36
PTGS2 P35354 1/20 0.36
KIF11 P52732 1/20 0.35
HAO1 Q9UJM8 1/20 0.35
MCL1 Q07820 2/20 0.35
BCL2 P10415 1/20 0.35
CTRC Q99895 1/20 0.35
FFAR1 O14842 1/20 0.35
DHODH Q02127 2/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21296949 0.85 ALPL (0.42) RXRARXRBRAB9AHAO1MCL1
SCHEMBL21312773 0.85 HAO1 (0.50) RXRARXRBNPC1RAB9AHAO1
SCHEMBL21312388 0.85 HAO1 (0.38) PTGS2HAO1MCL1CTRCDHODH
SCHEMBL21296860 0.85 KDM4E (0.38) TP53NPC1RAB9AHAO1CTRC
SCHEMBL29799105 0.83 KMO (0.46) NPC1RAB9AHAO1CTRC
SCHEMBL21312389 0.83 KMO (0.46) NPC1RAB9AHAO1CTRC
SCHEMBL21312707 0.82 RHEB (0.39) NPSR1HAO1MCL1CTRC
SCHEMBL21312777 0.82 PRKAG1 (0.48) RXRANPC1RAB9AHAO1
SCHEMBL21296965 0.80 SMN1; SMN2 (0.41) NPC1RAB9AHAO1USP2NOTUM
SCHEMBL21296958 0.80 HAO1 (0.54) HAO1CTRCCYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS VENTHERA, INC. 2021-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO RXRA 3619/4885RXRB 3335/4885RXRG 3640/4885
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO RXRA 3619/4885RXRB 3335/4885RXRG 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.